Genic
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Genic - overview
Established
2001
Location
Seongnam, Gyeonggi-do, South Korea
Primary Industry
Consumer Products
About
Genic is a skincare company specializing in innovative hydrogel masks that promote healthy beauty by providing deep hydration and nourishment, catering to a diverse consumer base in various international markets. Genic, founded in 2001, is based in Seongnam, South Korea, focusing on the skincare sector with its flagship hydrogel masks. The company has made two significant deals, with the most recent being a Private Placement/Follow on round in August 2011, raising KRW 14. 5 billion, which is the total amount raised to date.
There is no information regarding company pivots, subsidiaries, or previous company formations. Genic is primarily focused on manufacturing innovative skincare products, particularly its flagship hydrogel masks, which are designed to promote "healthy beauty. " These masks provide deep hydration and nourishment to the skin, catering to consumers seeking effective skincare solutions. Utilizing advanced skin technology, Genic's products meet the demand for high-quality personal care items.
Their customer base includes retail and wholesale partners, such as beauty salons and online retailers, distributing products across North America, Europe, and parts of Asia. The company prioritizes R&D, leading to the creation of several specialized mask variants that address various skin concerns. In 2024, Genic reported a revenue of KRW 36,616. 6 million and an EBITDA of KRW 5,620,416.
6. Moving forward, Genic plans to expand its product line with new hydrogel mask variants targeting specific skincare issues, expected to launch in late 2024. The company aims to penetrate new markets in Europe and North America by 2025, utilizing the KRW 14. 5 billion raised in its latest funding round to support these initiatives.
This funding will enhance their R&D capabilities and marketing efforts in these regions.
Primary Industry
Consumer Products
Sub Industries
Beauty & Hygiene
Website
www.genic21.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
Genic - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Private Placement/Follow on | Completed | Genic | - | ||||||||
| Buyout | Completed | Genic | - |
Displaying 1 - 2 of 2

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.